ČELESTINA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 11,497,646 | 14,099,928 | 15,988,762 | 16,594,414 | 17,436,346 | 22,160,411 | 30,272,370 | 27,461,133 |
| Profit before tax | 137,264 | 194,376 | 211,819 | 325,290 | 464,837 | 340,788 | 583,097 | 751,150 |
| Net profit | 115,100 | 163,422 | 179,383 | 273,891 | 392,722 | 259,210 | 476,842 | 617,201 |
| Equity | 3,906,522 | 4,009,944 | 4,117,227 | 4,292,314 | 4,471,019 | 4,430,229 | 4,557,071 | 4,774,272 |
| Liabilities | 6,078,384 | 7,557,199 | 6,792,669 | 7,648,328 | 5,973,653 | 6,161,385 | 4,302,065 | 5,823,077 |
| Non-current assets | 551,541 | 496,527 | 460,910 | 477,123 | 169,345 | 134,348 | 108,805 | 105,513 |
| Current assets | 9,433,365 | 11,070,616 | 10,448,986 | 11,463,519 | 10,275,327 | 10,455,155 | 8,748,827 | 10,489,652 |
| Total assets | 9,984,906 | 11,567,143 | 10,909,896 | 11,940,642 | 10,444,672 | 10,589,503 | 8,857,632 | 10,595,165 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | - | 112,716 | 56,484 |
| Social insurance contributions | - | - | - | - | - | 85,173 | 88,795 | 97,493 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +2.4% | +22.6% | +13.4% | +3.8% | +5.1% | +27.1% | +36.6% | -9.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 1.2% | 1.4% | 1.6% | 2.3% | 3.8% | 2.4% | 5.4% | 5.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 2.9% | 4.1% | 4.4% | 6.4% | 8.8% | 5.9% | 10.5% | 12.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.0% | 1.2% | 1.1% | 1.7% | 2.3% | 1.2% | 1.6% | 2.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 1.2% | 1.4% | 1.3% | 2.0% | 2.7% | 1.5% | 1.9% | 2.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.6 | 1.9 | 1.6 | 1.8 | 1.3 | 1.4 | 0.9 | 1.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 605,139 | 742,101 | 888,265 | 913,452 | 1,005,945 | 1,323,010 | 1,901,925 | 1,790,947 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
ČELESTINA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-05-17 | 2022-05-18 | 0.13 |
| 2022-04-28 | 2022-05-04 | 0.13 |
| 2022-02-17 | 2022-02-20 | 72.96 |
ČELESTINA - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
CELESTINA, UAB, a Private Limited Liability Company (code 122915610), operates in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €27.46M and net profit of €617.2K, corresponding to a profit margin of 2.2%. Revenue declined by 9.3% year on year after peaking at €30.27M in 2024, but the longer trend remains positive, with revenue up 23.9% compared with 2023. Net profit improved from €259.2K in 2023 to €476.8K in 2024 and then to €617.2K in 2025, indicating stronger profitability despite the weaker top line. At the end of 2025, total assets were €10.60M, equity €4.77M and liabilities €5.82M. The equity ratio stood at 45.1%, debt-to-equity at 1.22, asset turnover at 2.59x, ROE at 12.9% and ROA at 5.8%. Revenue per employee was €1.83M and profit per employee €41.1K.